000			01182 a2200325 4500
005			20250514003710.0
264		0	_c20010802
008			200108s 0 0 eng d
022			_a0891-1150
024	7		_a10.3949/ccjm.68.7.608 _2doi
040			_aNLM _beng _cNLM
100	1		_aHake, A M
245	0	0	_aUse of cholinesterase inhibitors for treatment of Alzheimer disease. _h[electronic resource]
260			_bCleveland Clinic journal of medicine _cJul 2001
300			_a608-9, 613-4, 616 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAlzheimer Disease _xdrug therapy
650	0	4	_aCarbamates _xtherapeutic use
650	0	4	_aCholinesterase Inhibitors _xtherapeutic use
650	0	4	_aDonepezil
650	0	4	_aGalantamine _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aIndans _xtherapeutic use
650	0	4	_aPhenylcarbamates
650	0	4	_aPiperidines _xtherapeutic use
650	0	4	_aRivastigmine
650	0	4	_aTacrine _xtherapeutic use
773	0		_tCleveland Clinic journal of medicine _gvol. 68 _gno. 7 _gp. 608-9, 613-4, 616
856	4	0	_uhttps://doi.org/10.3949/ccjm.68.7.608 _zAvailable from publisher's website
999			_c11381428 _d11381428